1.19 USD
▼-0.01-0.42%
盘后 1.33 0.00%
2026-09-16
市值
$75.88M
市盈率
—
EPS
-0.32
股息率
—
52 周区间
0.77 – 3.82
成交量
259.55K
Beta
1.29
目标价
5.53
52W 低 0.7752W 高 3.82
价格走势
公司简介
iBio, Inc., a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cardiometabolic and obesity space. The company’s technology platforms include EngageTx that provides a panel of optimized CD3 antibodies that can be paired with tumor-targeting antibodies to generate bispecific T-cell engagers; StableHu, an AI antibody-optimizing technology; and AI epitope steering technology, small binding sites on large target proteins Its product pipelines for cardiometabolic disease area...